References
Richardson PG, Riches ML, Kernan NA et al (2016) Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 127:1656–1665
Corbacioglu S, Carreras E, Mohty M et al (2016) Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the International Compassionate-Use Program. Biol Blood Marrow Transplant 22:1874–1882
Kernan NA, Grupp S, Smith AR, Arai S et al (2018) Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol 181:816–827
Mohty M, Battista ML, Blaise D et al (2021) A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study. Bone Marrow Transplant 56:2454–2463
Nauffal M, Kim HT, Richardson PG et al (2022) Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant. Blood Adv 6:181–188
Kong SG, Lee JH, Lim YT et al (2022) Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide. Korean J Intern Med 37:179–189
Shouval R, de Jong CN, Fein J et al (2018) Baseline renal function and albumin are powerful predictors for allogeneic transplantation-related mortality. Biol Blood Marrow Transplant 24:1685–1691
Schaffrath J, Diederichs T, Unverzagt S et al (2022) Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation. Ann Hematol 101:681–691
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statement
The study was performed in accordance with institutional ethical guidelines, including the World Medical Association Declaration of Helsinki, and was approved by the institutional review board (No. 021–0085).
Conflict of interest
Takanori Teshima received honoraria, research funding, and scholarship donation from NIPPON SHINYAKU.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shiratori, S., Okada, K., Matsuoka, S. et al. Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT. Ann Hematol 101, 2117–2118 (2022). https://doi.org/10.1007/s00277-022-04886-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-04886-9